Molecular pathology as the driving force for personalized oncology.

doi:10.1586/erm.12.121

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Molecular pathology as the driving force for personalized oncology.

Expert review of molecular diagnostics - 1 Nov 2012

Oktay Maja H, Hui Pei

Abstract excerpt

Innovative Tissue-Based Diagnostics Philadelphia, PA, USA, 4-5 June 2012 This article focuses on the current and emerging molecular diagnostics relevant to clinical practice of oncology discussed in the session of Molecular Pathology as the Driving Force for Personalized Oncology, one of the three main themes of innovative tissue-based diagnostics with the other two being pathology in cancer drug development,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Cytological Techniques
Share to Exome
Share to Immunohistochemistry
Share to Neoplasms
Share to Pathology, Molecular
Share to Precision Medicine
Share to Proto-Oncogene Proteins B-raf

Source

Open in PubMed

Identifiers

PMID: 23249199
DOI: 10.1586/erm.12.121

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics